Patents by Inventor Dirk BREDENBRÖKER

Dirk BREDENBRÖKER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Roflumilast for the treatment of diabetes mellitus type 2
    Patent number: 8541456
    Abstract: The application relates to specific combinations of Roflumilast and/or Roflumilast N-Oxide and a PPAR-agonist, as well as their use in the treatment of diabetes mellitus type 2.
    Type: Grant
    Filed: July 11, 2011
    Date of Patent: September 24, 2013
    Assignee: Takeda GmbH
    Inventors: Hans-Peter Kley, Guido Hanauer, Daniela Hauser, Beate Schmidt, Dirk Bredenbröker, Wilhelm Wurst, Jörg Kemkowski
  • Treatment Of Chronic Obstructive Pulmonary Disease With Phosphodiesterase-4 Inhibitor
    Publication number: 20120052122
    Abstract: Disclosed is a method of treatment of chronic obstructive pulmonary disease associated with chronic bronchitis in a patient at risk of exacerbations. The method includes administering to a patient with a history of chronic obstructive pulmonary disease associated with chronic bronchitis and at risk of exacerbations, a maintenance dose of 500 micrograms per day of roflumilast. Also disclosed is a method of increasing pre-bronchodilator FEV1 or post-bronchodilator FEV1 in such a patient, and increasing pre-bronchodilator FVC or post-bronchodilator FVC in such a patient. Further disclosed is a method of reducing the rate of exacerbations in such a patient.
    Type: Application
    Filed: August 24, 2011
    Publication date: March 1, 2012
    Applicant: Nycomed GmbH
    Inventor: Dirk Bredenbroeker
  • ROFLUMILAST FOR THE TREATMENT OF DIABETES MELLITUS
    Publication number: 20110269750
    Abstract: The application relates to specific combinations of Roflumilast and/or Roflumilast N-Oxide and a PPAR-agonist, as well as their use in the treatment of diabetes mellitus type 2.
    Type: Application
    Filed: July 11, 2011
    Publication date: November 3, 2011
    Applicant: NYCOMED GMBH
    Inventors: Hans-Peter KLEY, Guido HANAUER, Daniela HAUSER, Beate SCHMIDT, Dirk BREDENBRÖKER, Wilhelm WURST, Jörg KEMKOWSKI
  • Roflumilast for the treatment of diabetes mellitus
    Patent number: 8017633
    Abstract: The invention relates to the use of Roflumilast and/or Roflumilast N-Oxide for the treatment of diabetes mellitus and accompanying disorders thereof. The invention additionally relates to combinations of Roflumilast and/or Roflumilast N-Oxide with other active agents for the treatment of diabetes mellitus.
    Type: Grant
    Filed: March 3, 2006
    Date of Patent: September 13, 2011
    Assignee: Nycomed GmbH
    Inventors: Hans-Peter Kley, Guido Hanauer, Daniela Hauser, Beate Schmidt, Dirk Bredenbroeker, Wilhelm Wurst, Joerg Kemkowski